Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world
出版年份 2022 全文链接
标题
Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world
作者
关键词
-
出版物
Frontiers in Oncology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-11-25
DOI
10.3389/fonc.2022.954203
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study
- (2022) Mingyue Cai et al. Frontiers in Immunology
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma
- (2021) Jie Mei et al. Frontiers in Oncology
- Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study
- (2021) Zhigang Fu et al. Hepatology International
- Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma
- (2021) Liting Zhong et al. Frontiers in Oncology
- Immune checkpoint inhibitor plus tyrosine kinase inhibitor for unresectable hepatocellular carcinoma in the real world
- (2021) Diyang Xie et al. Annals of Translational Medicine
- Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development
- (2021) Xin Li et al. Frontiers in Molecular Biosciences
- Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first‐line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study
- (2021) Xiaoyan Ding et al. CANCER
- Efficacy and Safety of Transarterial Chemoembolization in Elderly Patients of Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Study
- (2021) Qinghe Tang et al. Frontiers in Oncology
- The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
- (2021) Patrizia Leone et al. Vaccines
- Therapeutic effectiveness and safety of sintilimab-dominated triple therapy in unresectable hepatocellular carcinoma
- (2021) Lei Dai et al. Scientific Reports
- TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study
- (2021) Biao Yang et al. Frontiers in Oncology
- Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
- (2021) Jia-Yi Wu et al. Journal of Hepatocellular Carcinoma
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Role of locoregional therapies in the wake of systemic therapy
- (2020) Daniel H. Palmer et al. JOURNAL OF HEPATOLOGY
- Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis
- (2020) Quan Rao et al. Hepatology International
- Efficacy and Safety of SBRT Combined With Camrelizumab and Apatinib in HCC Patients With PVTT: Study Protocol of a Randomized Controlled Trial
- (2020) Yue Hu et al. Frontiers in Oncology
- Transarterial chemoembolization enhances programmed death 1 and programmed death‐ligand 1 expression in hepatocellular carcinoma
- (2020) Ahmed Montasser et al. HISTOPATHOLOGY
- Efficacy and safety of drug‑eluting beads for transarterial chemoembolization in patients with advanced hepatocellular carcinoma
- (2019) Wen‑Zhen Cao et al. Experimental and Therapeutic Medicine
- Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy
- (2019) Chi-Leung Chiang et al. Frontiers in Oncology
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- An EHBH-PVTT scoring system as an aid to decision-making on hepatectomy for HCC patients with PVTT: a multicenter study
- (2018) Xiu-Ping Zhang et al. HEPATOLOGY
- Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
- (2018) Masatoshi Kudo Cancers
- Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
- (2017) XiuPing Zhang et al. Oncotarget
- Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
- (2016) Takashi Kokudo et al. JOURNAL OF HEPATOLOGY
- The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus
- (2015) Zong-ming Zhang et al. International Journal of Surgery
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Safety and Efficacy of Doxorubicin Drug-eluting Bead Transarterial Chemoembolization in Patients with Advanced Hepatocellular Carcinoma
- (2013) Hasmukh J. Prajapati et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started